Brief: SK Biopharmaceuticals, Eurofarma Enter Into Licensing Agreement For Cenobamate In Latin America

SK Biopharmaceuticals Co

14/07/2022 14:48

July 14 (Reuters) - SK Biopharmaceuticals Co Ltd
 326030.KS :
    * SK BIOPHARMACEUTICALS, EUROFARMA ENTER INTO LICENSING
AGREEMENT
FOR CENOBAMATE IN LATIN AMERICA
    * SK BIOPHARMACEUTICALS CO LTD - IN DEAL, CO WILL RECEIVE AN
UPFRONT PAYMENT OF US$15 MILLION FROM EUROFARMA
    * SK BIOPHARMACEUTICALS - IN DEAL, CO ELIGIBLE TO RECEIVE
FUTURE
MILESTONES OF UP TO US$47 MILLION, WITH ROYALTIES ON SALES
GENERATED IN LATIN AMERICA

Source text for Eikon:  ID:nPn9DC6CVa 
Further company coverage:  326030.KS